Weaver C. Barksdale Associates buys $1,014,446 stake in AFLAC Incorporated (AFL)

AFLAC Incorporated (AFL) : Weaver C. Barksdale Associates scooped up 749 additional shares in AFLAC Incorporated during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 12, 2016. The investment management firm now holds a total of 14,292 shares of AFLAC Incorporated which is valued at $1,014,446.AFLAC Incorporated makes up approximately 1.74% of Weaver C. Barksdale Associates’s portfolio.

Other Hedge Funds, Including , Legacy Private Trust boosted its stake in AFL in the latest quarter, The investment management firm added 1,330 additional shares and now holds a total of 26,422 shares of AFLAC Incorporated which is valued at $1,875,434. AFLAC Incorporated makes up approx 0.26% of Legacy Private Trust’s portfolio. Contravisory Investment Management sold out all of its stake in AFL during the most recent quarter. The investment firm sold 29 shares of AFL which is valued $2,079.Telemus Capital boosted its stake in AFL in the latest quarter, The investment management firm added 1,044 additional shares and now holds a total of 13,242 shares of AFLAC Incorporated which is valued at $952,100. AFLAC Incorporated makes up approx 0.11% of Telemus Capital’s portfolio.West Oak Capital reduced its stake in AFL by selling 50 shares or 0.5% in the most recent quarter. The Hedge Fund company now holds 10,010 shares of AFL which is valued at $719,719. AFLAC Incorporated makes up approx 0.50% of West Oak Capital’s portfolio.Beacon Financial Group reduced its stake in AFL by selling 524 shares or 5.57% in the most recent quarter. The Hedge Fund company now holds 8,880 shares of AFL which is valued at $638,472. AFLAC Incorporated makes up approx 0.13% of Beacon Financial Group’s portfolio.

AFLAC Incorporated closed down -0.7 points or -0.98% at $70.98 with 13,50,623 shares getting traded on Tuesday. Post opening the session at $71.59, the shares hit an intraday low of $70.73 and an intraday high of $71.64 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, AFLAC Incorporated reported $1.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.68. The company had revenue of $5437.00 million for the quarter, compared to analysts expectations of $5469.99 million. The company’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.50 EPS.

Many Wall Street Analysts have commented on AFLAC Incorporated. AFLAC Incorporated was Initiated by Credit Suisse to “Underperform” on Oct 7, 2016. AFLAC Incorporated was Resumed by Wells Fargo to “Market Perform” on Sep 23, 2016.

Aflac Incorporated (Aflac) is a business holding company. The Company is engaged in supplemental health and life insurance which is marketed and administered through its subsidiary American Family Life Assurance Company of Columbus (Aflac). Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products including cancer plans medical indemnity plans medical/sickness riders care plans living benefit life plans ordinary life insurance plans and annuities. Aflac U.S. sells insurance products including products designed to protect individuals from depletion of assets such as accident cancer critical illness/care hospital intensive care hospital indemnity fixed-benefit dental and vision care plans and loss-of-income products.

Leave a Reply

AFLAC Incorporated - Is it time to Sell?

Top Brokerage Firms are advising their investors on AFLAC Incorporated. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.